Literature DB >> 34957702

Looking Into the Crystal Ball: A Novel Biomarker for Outcomes of Patients With Chronic Hepatitis B Virus Infection.

Tai-Chung Tseng1,2,3, Jer-Wei Wu4, Jia-Horng Kao1,2,3,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34957702      PMCID： PMC8710796          DOI： 10.1002/hep4.1856

Source DB:  PubMed          Journal:  Hepatol Commun        ISSN： 2471-254X


× No keyword cloud information.
  9 in total

1.  Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients.

Authors:  Lilian Yan Liang; Vincent Wai-Sun Wong; Hidenori Toyoda; Yee-Kit Tse; Terry Cheuk-Fung Yip; Becky Wing-Yan Yuen; Toshifumi Tada; Takashi Kumada; Hye-Won Lee; Grace Chung-Yan Lui; Henry Lik-Yuen Chan; Grace Lai-Hung Wong
Journal:  J Gastroenterol       Date:  2020-06-17       Impact factor: 7.527

2.  High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.

Authors:  Tai-Chung Tseng; Chun-Jen Liu; Chen-Yang Hsu; Chun-Ming Hong; Tung-Hung Su; Wan-Ting Yang; Chi-Ling Chen; Hung-Chih Yang; Yen-Tsung Huang; Stephanie Fang-Tzu Kuo; Chen-Hua Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Gastroenterology       Date:  2019-08-27       Impact factor: 22.682

3.  Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.

Authors:  Barbara Testoni; Fanny Lebossé; Caroline Scholtes; Françoise Berby; Clothilde Miaglia; Miroslava Subic; Alessandro Loglio; Floriana Facchetti; Pietro Lampertico; Massimo Levrero; Fabien Zoulim
Journal:  J Hepatol       Date:  2018-12-07       Impact factor: 25.083

4.  Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load.

Authors:  Tai-Chung Tseng; Chun-Jen Liu; Wan-Ting Yang; Chen-Yang Hsu; Chun-Ming Hong; Tung-Hung Su; Cheng-Hsueh Tsai; Chi-Ling Chen; Hung-Chih Yang; Chen-Hua Liu; Hsiu-Hsi Chen; Pei-Jer Chen; Jia-Horng Kao
Journal:  Aliment Pharmacol Ther       Date:  2021-01-19       Impact factor: 8.171

5.  Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues.

Authors:  Tetsuya Hosaka; Fumitaka Suzuki; Masahiro Kobayashi; Shunichirou Fujiyama; Yusuke Kawamura; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Mariko Kobayashi; Hiromitsu Kumada
Journal:  Aliment Pharmacol Ther       Date:  2019-01-20       Impact factor: 8.171

6.  Characterization of Hepatitis B Precore/Core-Related Antigens.

Authors:  Xupeng Hong; Laurie Luckenbaugh; Megan Mendenhall; Renae Walsh; Liza Cabuang; Sally Soppe; Peter A Revill; Dara Burdette; Becket Feierbach; William Delaney; Jianming Hu
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

Review 7.  Elimination of Hepatitis B: Is It a Mission Possible?

Authors:  Tai-Chung Tseng; Jia-Horng Kao
Journal:  BMC Med       Date:  2017-03-15       Impact factor: 8.775

8.  Ultrasensitive Assay for Hepatitis B Core-Related Antigen Predicts Hepatocellular Carcinoma Incidences During Entecavir.

Authors:  Tetsuya Hosaka; Fumitaka Suzuki; Mariko Kobayashi; Shunichiro Fujiyama; Yusuke Kawamura; Hitomi Sezaki; Norio Akuta; Masahiro Kobayashi; Yoshiyuki Suzuki; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Hiromitsu Kumada
Journal:  Hepatol Commun       Date:  2021-09-16

Review 9.  Three Heads are Better than Two: HBcrAg as a New Predictor of HBV-related HCC.

Authors:  Jer-Wei Wu; Jia-Horng Kao; Tai-Chung Tseng
Journal:  Clin Mol Hepatol       Date:  2021-02-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.